Amylyx

Performance

About Amylyx

Amylyx is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet medical needs. The company describes its mission as advancing a pipeline of investigational therapies with rigorous science, aiming to deliver meaningful clinical outcomes and biomarkers across neurologic and metabolic conditions. Its programs span diseases such as amyotrophic lateral sclerosis (ALS), Wolfram syndrome, and post-bariatric hypoglycemia (PBH), with a global approach to research and patient communities. Headquartered in a manner consistent with its global operations, Amylyx emphasizes urgency, integrity, and collaboration with patient communities and healthcare professionals.